Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided dorsal scapular nerve vs myofascial trigger point injection for upper back myofascial pain
ChiCTR2100041884Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine and botulinum toxin type A in chronic myofascial pain (CMP) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: NRS score. Started Mar 2021; status: recruiting.
02
Drugs
ropivacainebotulinum toxin type A
03
Conditions
chronic myofascial pain (CMP)
Beyond the preview
Go deeper on ChiCTR2100041884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041884.